Skip to main content
×
Login
Submit a Manuscript
Home
Journal
Current Issue
Archive
For Authors
Column Series
Research & Insight
Special Reports
Subscribe
Resources
Blogs
Expert Insights
Latest News
Pathways Beyond Oncology
Topics
Comparative Effectiveness Research
Cost-Effectiveness Research
COVID-19 Updates
Guideline Updates
Health Economics and Outcomes Research
Health Technology
Real-World Data
Reimbursement
Value-Based Care
Specialties
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
B-Cell Lymphoma
Biosimilars
Bladder Cancer
Breast Cancer
CAR-T Therapies
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Colorectal Cancer
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Immuno-Oncology
Kidney Cancer
Liver Cancer
Lung Cancer
Mantle Cell Lymphoma
Melanoma
Multiple Myeloma
Non-Small Cell Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Skin Cancer
Supportive Care
Excellence Forums
Mantle Cell Lymphoma Excellence Forum
Conferences
Oncology Clinical Pathways Congress
ASCO Gastrointestinal Cancers Symposium
ACCC Annual Meeting & Cancer Center Business Summit
ASCO Genitourinary Cancers Symposium
ASH Annual Meeting and Exposition
Oncology CME
About
About Us
Contact
Biosimilars
Featured
News
Remaining Challenges, Potential Solutions for the Regulatory Evaluation of Biosimilars
A recent article outlines challenges that remain regarding the regulatory evaluation of biosimilars and offers potential solutions for the future.
News
Policy Review on Improving Oncology Biosimilar Launches
A recent policy review identifies factors that prevent the effective launch of oncology biosimilars.
News
Rituximab and Trastuzumab Biosimilars Yield Acceptable Safety in Real-World Setting
Biosimilar rituximab and biosimilar trastuzumab are associated with acceptable safety profiles among patients with…
News
ACP Recommendations for Improving Market Competition
A position paper released by the American College of Physicians made concrete policy reform suggestions for…
Quiz
Quiz: Does Pegfilgrastim Biosimilar Increase Value of Cancer Care?
True or False: Chemotherapy-induced febrile neutropenia prophylaxis with biosimilar pegfilgrastim-bmez increases the…
News
Remaining Challenges, Potential Solutions for the Regulatory Evaluation of Biosimilars
Policy Review on Improving Oncology Biosimilar Launches
Rituximab and Trastuzumab Biosimilars Yield Acceptable Safety in Real-World Setting
ACP Recommendations for Improving Market Competition
Guideline Updates
ASCO, ASH Guideline Supports Safety, Efficacy of Biosimilar for Managing Anemia
Interviews
Making the Switch to Biosimilars With Clinical Pathways
Blog
Biosimilars in Oncology: ASCO's Position Statement and the Anticipated Cost-Savings
Podcast
Episode 45: Simplifying Biosimilars With Gary Lyman
Stay in the know.
Journal of Clinical Pathways Newsletter
Back to Top